Core Insights - The rise of kale as a popular ingredient in health-focused beverages reflects a shift in consumer preferences towards low-calorie and low-fat diets, driven by the trend of "light eating" and weight loss [1][2] - The price of kale has significantly increased from a few cents per pound to 3.5 yuan per pound, indicating its growing market value and demand [1] - The success of kale in the beverage market is attributed to continuous product innovation by tea brands, which have improved its taste and positioned it as a fashionable health product [2] Industry Trends - The health food market is characterized by three main trends: functional demand, scenario-based consumption, and social currency attributes [2] - The popularity of kale beverages exemplifies these trends, as tea brands have effectively addressed the taste issues associated with kale and created products that combine health benefits with trendy appeal [2] - The emergence of large-scale kale cultivation bases in regions like Shandong and Guangxi, utilizing modern greenhouse and organic farming techniques, ensures the stability of raw material quality [2] Market Dynamics - The rise of kale represents a quality revolution in China's consumer market, where consumers are increasingly seeking healthier and higher-quality lifestyles [2] - The innovation across the entire supply chain has led to the development of diverse products such as freeze-dried powder, composite fruit and vegetable juices, and snacks, enhancing product value and catering to various consumption scenarios [2] - Companies that can effectively capture and respond to these evolving consumer demands through continuous innovation are likely to gain a competitive edge in the market [2]

*ST旭蓝（000040）：*ST旭蓝是一家主要从事光伏发电技术及设备研发、制造和销售的企业。公司股 票在2024年12月31日至2025年3月31日期间，连续20个交易日的收盘价均低于1元，触及退市标准。公司 实际控制人李兆廷因涉嫌信息披露违法违规被证监会立案调查，进一步加剧了公司的经营困境。截至最 后一个交易日，*ST旭蓝的股价定格在0.49元，市值7.29亿元。 *ST嘉寓（300117）：*ST嘉寓是一家专注于建筑产品的公司，主要业务包括节能门窗幕墙的设计、生 产和安装。公司在2025年3月4日至3月31日期间，连续20个交易日的收盘价低于1元而被终止上市。2025 年一季度，*ST嘉寓的营业收入大幅下滑，归母净利润为-548.48万元，扣非净利润为-1.65亿元，财务状 况堪忧。此外，4月27日公司新增2条被执行人信息，执行标的5019.97万元，进一步暴露了其财务风 险。 *ST东方（600811）：*ST东方主营业务涉及现代农业及健康食品产业。公司股票在2025年3月14日至4 月14日期间，连续20个交易日的收盘价均低于1元，触及退市标准。公司还因涉嫌信息披露违法违规， 被证监会立案调查。20 ...

Group 1 - The event "2025 Guangxi March 3rd Health Spring Voice" was held in Lipu City, showcasing 37 health product companies and attracting significant public participation [1] - The event aligns with the "Promoting Healthy Consumption Special Action Plan" issued by multiple government departments, aiming to enhance health consumption levels and promote diverse health industry development [1] - Companies like Guilin Yuanzhinda Biotechnology Co., Ltd. are seizing the opportunity to expand their health product offerings, with plans to open 10 stores within the year [2] Group 2 - Jinhuai, a type of locust tree, is being utilized by companies to create a range of health products, including tea and medicinal dishes, capitalizing on its recognition in the food and medicine category [2] - The Guangxi Yongfu Fuzhongfu Luo Han Guo Co., Ltd. is also developing diverse products from Luo Han Guo, aiming to enhance collaboration with other companies for mutual growth [2] - The Guangxi District Forest Farm Under-Economic Green Industry Association is promoting health products and plans to establish an online health product store to enhance market reach [3]

Core Viewpoint - Baolingbao achieved significant growth in Q1 2025, with a revenue of 685 million yuan, a year-on-year increase of 24.23%, and a net profit of 50.36 million yuan, up 117.35%, both reaching historical highs for the period [1] Group 1: Financial Performance - The company's comprehensive gross profit margin increased to 13.65%, up 3.67% from the same period last year [1] - The gross profit margin for the three core products (prebiotics, dietary fiber, and sugar-reducing sweeteners) reached 18.36% [1] Group 2: Product Demand and Market Strategy - There is a growing demand for sugar-reducing sweeteners, with the company's revenue from these products increasing by approximately 96% in Q1 [2] - The revenue growth for specific products includes erythritol (up 123%), allulose (up 82%), and crystalline fructose (up 80%) [2] Group 3: Project Development and Innovation - The production lines for DHA algae oil, lactulose, and HMOs have been completed and are in trial production [2] - The company has initiated the expansion project for allulose and is actively advancing the approval process for HMOs and allulose [2] - In Q1 2025, the company received three invention patent authorizations and participated in multiple industry standard formulations [2] Group 4: Market Outlook and Strategic Focus - The health food market is expected to enter a golden development period, with increasing consumer demand for functional ingredients like prebiotics and dietary fiber [2] - The company aims to leverage its technological advantages and market position to optimize product structure and innovate, adopting a "small, fine, and agile" model to meet differentiated demands [2] - Baolingbao plans to expand its domestic and international markets by utilizing its global layout and brand strength [2]

突破传统，探索科学管理新方向 在全民关注健康的趋势下，传统减重方式的局限性逐渐显现。部分人群采用的过度节食方法，虽然可能 在短期内使体重下降，但往往会对身体代谢功能造成不良影响，甚至引发后续的体重波动。这些现象让 人们意识到，体重管理不应是追求短期效果的"突击战"，而需要从长远出发，以科学的方式调节身体代 谢。Melrose麦萝氏秉持这样的理念，携新品绿瘦子2.0，帮助人们建立健康的生活方式。 品质传承，坚守匠心精神 在健康食品领域，Melrose麦萝氏无疑是一颗璀璨的明星。自1979年由化学家Geoff Steinicke 创立以来， Melrose麦萝氏已在澳大利亚健康食品行业深耕46年。Melrose麦萝氏在澳大利亚墨尔本设有现代化工 厂，获TGA认证。工厂内自动化生产线与先进包装线协同运作，整体工艺设计凭借创新与匠心，荣获 澳洲建筑师设计大奖。每一款产品都要经过质检团队严格把关，通过感官测试、微量元素检测等多道工 序，确保品质可靠。 截止2025年，全球范围内，已有超21亿成年人面临超重或肥胖问题，我国相关人群数量也突破5.2亿。 在这样的背景下，澳大利亚国民级健康食品品牌Melrose麦萝氏凭借四十 ...

最近，一则重磅消息在网络上刷屏——国家卫生健康委员会郑重宣布,正式启动为期三年的《体重管理 年》专项行动，力促全民健康素养提升。相关数据令人警醒，我国成年居民超重率已攀升至34.3%，肥 胖率也达到了16.4%，肥胖与高血压、糖尿病、心脑血管疾病等多种慢性病紧密相连，成为威胁国民健 康的重大隐患。 当身体出现脂肪堆积，尤其是内脏脂肪含量上升时，会对健康产生潜在影响。研究表明，脂肪过度积累 可能与内分泌波动、胰岛素敏感性变化相关，进而增加2型糖尿病的患病风险；同时还可能影响心血管 健康，导致血脂水平异常、动脉健康状况改变；此外，还可能引发身体炎症反应、加重关节负担，影响 日常生活质量。因此，科学管理体重、改善身体代谢状态成为健康生活的重要课题。作为澳洲知名健康 食品品牌，Melrose麦萝氏推出绿瘦子1.0的升级产品：有机绿植精萃代谢粉2.0。这款产品将专利科技与 天然营养相结合，为消费者提供科学的体重管理参考方案，帮助人们以更健康、更科学的方式管理身体 状态，探索适合自己的健康生活路径。 专利科技，构建科学体重管理矩阵 Melrose麦萝氏绿瘦子2.0 搭载两大专利成分，构建科学体重管理矩阵。VInOgrap ...

自2017年乡村振兴战略提出以来，国家及各部委发布了一系列政策文件。2025年初，《乡村全面振兴规划 (2024—2027年)》和《中共中央国务院关于进一步深化农村改革扎实推进乡村全面振兴的意见》相继出 台，为推进乡村全面振兴提供了有力的政策支撑和行动指南。 自政策出台以来，御君方坚决贯彻党中央关于乡村振兴战略部署，积极响应有关乡村振兴工作号召，充分 发挥产业链和资源整合优势，在国家乡村振兴战略全面推进的关键时期，御君方紧紧围绕地方特色产品、 产业，以"原料产地化、生产科技化、产品市场化"的模式，将传统农业与食品、中药材等加工业深度绑 定，共同开发产品，切实有力带动乡镇百姓稳定就业、增加收入，成为乡村振兴道路上的创新典范。 精选道地药材，助力乡村发展 在中医药产业蓬勃发展的浪潮中，御君方以道地药材为核心，积极构建全产业链标准化模式，通过质量管 控与科技创新双轮驱动，为中医药产业高质量发展注入强劲动力，同时也为乡村振兴绘下浓墨重彩的一 笔。 自品牌创立，御君方持续开展全国优质药材产地探访行动。专家团队奔赴四川阿坝州，精选被誉为"大山 里的药材黄金，中医里的养肺圣药"的川贝母，制成川贝母粉；远赴云南挑选珍贵龙血树 ...

Group 1: Company Performance - In Q1 2025, the company achieved a net profit of 68.64 million RMB, representing an 8.90% year-on-year increase [6] - The gross profit margin for Q1 2025 was 33.09%, an increase of 2.47 percentage points compared to the same period last year [6] - For the full year 2024, the company reported total revenue of 4.21 billion RMB, a 17.6% increase year-on-year, and a net profit of 325 million RMB, up 15.7% [8] Group 2: Market and Growth Strategy - The Chinese nutrition and health food market is projected to reach 260.2 billion RMB in 2024, with a CAGR of 6.3% from 2019 to 2024 [8] - The company plans to enhance its global smart supply chain capabilities and strengthen collaboration between domestic and international operations [2][7] - The company aims to expand its domestic market share by focusing on high-value clients and exploring new consumption channels such as live streaming and offline retail [2][7] Group 3: International Business and Challenges - Approximately 60% of the company's business is international, with 40% coming from the U.S. market [3] - The company is actively managing the impact of tariffs on its U.S. exports, with less than 15% of its total revenue coming from exports to the U.S. [3] - The company is exploring local production options in the U.S. to mitigate tariff impacts and enhance its supply chain resilience [3] Group 4: Product Development and Innovation - The company focuses on six key functional areas: anti-aging, probiotics, beauty and health, cardiovascular metabolism, immune enhancement, and bone and joint health [5] - The company is developing a "Xianle Probiotic Technology Platform" to lead the probiotics industry and is responding to national initiatives on weight management with new product launches [5] - The production capacity utilization rate for gummies and bagged drinks exceeded 70% as of March 2025, while powder products still have room for improvement [4]

以下文章来源于精练GymSquare ，作者陈五花 精练GymSquare . 精练GYMSQUARE是中国领先的健身和运动生活方式产业服务品牌。通过深度和前沿的行业洞察，服务中国健身和健康新经济，持续聚焦大健身产业、 教练职业和用户运动趋势。我们强调原创与价值创造：与精益练习者，建造自由运动广场。 国家喊你减肥。 文 ｜ 陈五花 编辑 ｜ GymSquare编辑部 来源｜ 精练GymSquare（ID：GymSquare） 封面来源 ｜ Pexels 国家层面"体重管理年"三年行动的提出，健身和健康关注度来到新高。 2025年3月9日，在十四届全国人大三次会议民生主题记者会上，国家卫生健康委员会主任雷海潮用长达7分钟的时间介绍了体重管理相关的工作，并表示 继续实施从去年提出的"体重管理年"3年行动，普及健康生活方式，加强慢性病防治。 体重管理年活动的出台，主要源于国人亟待解决的肥胖问题。《柳叶刀》的最新研究报告中指出，直到2021年，中国25岁及以上成年超重和肥胖患者达到 4.02亿，数量全球居首。 根据我国2024年肥胖症诊疗指南，肥胖症已成为我国重大公共卫生问题，是我国第六大致死致残主要危险因素。 图源 ...